LATAM Career News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Career News.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on October 8, 2025

October 8, 2025

Wicked Oaks Festival - Halloween Event Austin Texas

EIN Presswire

October 8, 2025

Puerta del Lobo Breaks Ground on Landmark Texas Winery and Luxury Development

EIN Presswire

October 8, 2025

Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo

GlobeNewswire

October 8, 2025

ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…

GlobeNewswire

October 8, 2025

Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif

GlobeNewswire

October 8, 2025

Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO

GlobeNewswire

October 8, 2025

Nilo Therapeutics 啟動 1.01 億美元 A 輪融資，推進針對免疫疾病神經迴路的新型藥物研發，並任命 Kim Seth 為行政總裁

GlobeNewswire

October 8, 2025

Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…

GlobeNewswire

October 8, 2025

Nilo Therapeutics เปิดตัวด้วยการระดมทุนรอบ Series A มูลค่าถึง 101 ล้านเหรียญสหรัฐ เพื่อพัฒนายาประเภทใหม่ที่มุ่งเป้าไปที่วงจรระบบประสาทในโรคภูมิคุ้มกัน รวมถึงแต่งตั้ง Kim Seth เป็นประธานเจ้าหน้าที่บริหา…

GlobeNewswire

October 8, 2025

Nilo Therapeutics 启动 1.01 亿美元 A 轮融资，以推进靶向免疫疾病神经回路的新型药物研发，并任命 Kim Seth 为首席执行官

GlobeNewswire

October 8, 2025

Kentucky First Federal Bancorp Announces Management Transition

GlobeNewswire

October 8, 2025

Hedy AI Partners with Koerting Institute to Bring Real-Time AI Meeting Intelligence to European Business Leaders

GlobeNewswire

October 8, 2025

374Water Appoints Stephen J. Jones as Interim President and Chief Executive Officer

GlobeNewswire

October 8, 2025

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the WideOpenWest Buyout by DigitalBridge and Crestview Partners

GlobeNewswire

October 8, 2025

FX Utopia Introduces AI-Powered Instant Funding Accounts for Traders Seeking Real Capital Access

GlobeNewswire

October 8, 2025

Small Business Week: BDC Encourages Entrepreneurs to Prepare for the “Economic Revolution”

GlobeNewswire

October 8, 2025

Semaine de la PME : BDC encourage les PME à se préparer à la « révolution économique »

GlobeNewswire

October 8, 2025

OFL: Workers pay the price as Ford’s Conservatives slash employment law enforcement

GlobeNewswire

October 8, 2025

Milind Joshi Joins Striim as VP of Payment Solutions to Drive Enterprise Payments, ERP Integrations, and AI-Ready Data Innovation

GlobeNewswire

October 8, 2025

Rheumatoid Arthritis Therapies Market to Hit $41.1B by 2030

GlobeNewswire